417 related articles for article (PubMed ID: 8277101)
1. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility.
Snapper HJ; Shea NL; Konstam MA; Oates E; Udelson JE
J Nucl Cardiol; 1997; 4(1 Pt 1):3-10. PubMed ID: 9138837
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
Soufer R; Dey HM; Ng CK; Zaret BL
Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
[TBL] [Abstract][Full Text] [Related]
5. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both.
Arrighi JA; Ng CK; Dey HM; Wackers FJ; Soufer R
Am J Cardiol; 1997 Oct; 80(8):1007-13. PubMed ID: 9352969
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
[TBL] [Abstract][Full Text] [Related]
7. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.
Berman DS; Kiat H; Friedman JD; Wang FP; van Train K; Matzer L; Maddahi J; Germano G
J Am Coll Cardiol; 1993 Nov; 22(5):1455-64. PubMed ID: 8227805
[TBL] [Abstract][Full Text] [Related]
8. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
9. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy.
Chua T; Kiat H; Germano G; Maurer G; van Train K; Friedman J; Berman D
J Am Coll Cardiol; 1994 Apr; 23(5):1107-14. PubMed ID: 8144776
[TBL] [Abstract][Full Text] [Related]
10. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.
Sciagrà R; Bisi G; Santoro GM; Zerauschek F; Sestini S; Pedenovi P; Pappagallo R; Fazzini PF
J Am Coll Cardiol; 1997 Aug; 30(2):384-91. PubMed ID: 9247509
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of single-isotope and dual-isotope stress-rest single-photon emission computed tomographic imaging for reversibility of defects.
Siebelink HM; Natale D; Sinusas AJ; Wackers FJ
J Nucl Cardiol; 1996; 3(6 Pt 1):483-93. PubMed ID: 8989673
[TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
[TBL] [Abstract][Full Text] [Related]
14. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
Duncan BH; Ahlberg AW; Levine MG; McGill CC; Mann A; White MP; Mather JF; Waters DD; Heller GV
Am J Cardiol; 2000 Mar; 85(6):680-4. PubMed ID: 12000040
[TBL] [Abstract][Full Text] [Related]
15. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
17. Technetium 94m-labeled methoxyisobutyl isonitrile: dosimetry and resting cardiac imaging with positron emission tomography.
Stone CK; Christian BT; Nickles RJ; Perlman SB
J Nucl Cardiol; 1994; 1(5 Pt 1):425-33. PubMed ID: 9420726
[TBL] [Abstract][Full Text] [Related]
18. Detecting myocardial salvage after primary PTCA: early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging.
Sciagrà R; Bolognese L; Rovai D; Sestini S; Santoro GM; Cerisano G; Marini C; Buonamici P; Antoniucci D; Fazzini PF
J Nucl Med; 1999 Mar; 40(3):363-70. PubMed ID: 10086696
[TBL] [Abstract][Full Text] [Related]
19. Additive value of low-dose dobutamine to technetium-99m sestamibi-gated single-photon emission computed tomography for prediction of wall motion improvement in patients undergoing coronary artery bypass graft.
Zafrir N; Arditi A; Ben-Gal T; Solodky A; Hassid Y; Sulkes J; Battler A
Clin Cardiol; 2003 Nov; 26(11):530-5. PubMed ID: 14640470
[TBL] [Abstract][Full Text] [Related]
20. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
